Deep Bio's AI Algorithm Revolutionizes Breast Cancer Analysis

Deep Bio today announced the publication of a study evaluating the performance of its AI algorithm for breast cancer analysis to accurately differentiate between invasive ductal carcinoma (IDC) lesions from non-invasive ductal carcinoma in situ (DCIS) lesions in biopsies taken after breast cancer surgery.

Related Keywords

Bucheon ,Kyonggi Do ,South Korea ,Laura Thomsonmay ,Yeong Kwak ,Catholic University Of Korea Bucheon St ,Korean Breast Cancer Society ,Korea University Guro Hospital ,Catholic University ,Korea Bucheon ,Artificial Intelligence ,Breast Cancer White ,Deep Bio ,Multi Resolution Selective Segmentation Model ,Breast Cancer ,Sentinel Lymph Node Biopsy ,